Cash from Financing (Quarterly) Chart

View Cash from Financing (Quarterly) for HIMS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Financing (Quarterly) Chart
Start Trial

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 341.76M
March 31, 2026 -77.88M
December 31, 2025 -100.91M
September 30, 2025 -38.66M
June 30, 2025 890.98M
March 31, 2025 -21.78M
December 31, 2024 -13.65M
September 30, 2024 -38.82M
June 30, 2024 -25.06M
March 31, 2024 -30.31M
December 31, 2023 -3.963M
September 30, 2023 -1.559M
June 30, 2023 -2.541M
March 31, 2023 -3.412M
Date Value
December 31, 2022 -10.46M
September 30, 2022 -0.494M
June 30, 2022 0.353M
March 31, 2022 -22.53M
December 31, 2021 -0.078M
September 30, 2021 -0.484M
June 30, 2021 -4.34M
March 31, 2021 239.94M
December 31, 2020 -0.707M
September 30, 2020 12.37M
June 30, 2020 5.747M
March 31, 2020 30.34M
December 31, 2019 -0.2367M
September 30, 2019 203.24M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
HealthEquity, Inc. -119.61M
Claritev Corp. -61.64M
CVS Health Corp. -2.693B
Eli Lilly & Co. 8.426B
Ontrak, Inc. --